ClinicalTrials.Veeva

Menu
B

Be Well Clinical Studies | Lincoln, NE

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

LY3154207
S-309309
Mevidalen
[18F]PI-2620
VX-548

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 21 total trials

[18F]PI-2620 Phase 3 Histopathological Study

This study is an open-label, multi-center, non-randomized pivotal Phase 3 study to assess the efficacy and safety of PET imaging with \[18F\]PI-2620...

Enrolling
Alzheimer Disease
Drug: [18F]PI-2620

The main purpose of this study is to look at how safe the study drug (mevidalen) is and whether it works to alleviate symptoms when given to people w...

Enrolling
Alzheimer Disease
Drug: Placebo
Drug: Mevidalen

The purpose of this study is to demonstrate the efficacy of 9-valent extraintestinal pathogenic Escherichia coli vaccine (ExPEC9V) compared to placeb...

Active, not recruiting
Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention
Biological: ExPEC9V
Other: Placebo

This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity an...

Active, not recruiting
SARS-CoV-2 Infection
Biological: Intramuscular vaccine
Drug: Intramuscular injection

The purpose of VAN00010 study is to assess the safety and immunogenicity of the investigational pentavalent meningococcal ABCYW vaccine in adults and...

Active, not recruiting
Healthy Volunteers
Meningococcal Immunisation
Biological: Pentavalent Meningococcal ABCYW vaccine
Biological: MenABCYW conjugate vaccine

The goal of this clinical study is to learn more about the study drug, obeldesivir (ODV; GS-5245), and how safe and effective it is in treating nonho...

Active, not recruiting
RSV Infection
Drug: Obeldesivir
Drug: Obeldesivir Placebo

This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary...

Active, not recruiting
COVID-19
Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)
Other: Placebo

This is a proof-of-concept study to assess the safety and efficacy of Nimacimab Injection compared to an active and placebo injection control.

Active, not recruiting
Obesity
Biological: Nimacimab placebo injection
Biological: Nimacimab injection

Trial sponsors

Moderna logo
Sanofi logo
Pfizer logo
Abbott logo
Gilead Sciences logo
Janssen (J&J Innovative Medicine) logo
Janssen (J&J Innovative Medicine) logo
L
Lilly logo
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems